跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIMPAT lacosamide 10 mg/mL oral solution bottle - TGA Drug Approval Details
Approvals
/
TGA
/
VIMPAT lacosamide 10 mg/mL oral solution bottle
Approved
STANDARD
VIMPAT lacosamide 10 mg/mL oral solution bottle
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
895d543bc2fead6e
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
895d543bc2fead6e
Product Name
VIMPAT lacosamide 10 mg/mL oral solution bottle
Artg Id
286810
Artg Name
VIMPAT lacosamide 10 mg/mL oral solution bottle
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2018-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3105d459640ea4d7fcfb241405a88dd0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/581f82d094331087fd059f88c01de91f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
895d543bc2fead6e
Type
Standard
Back to TGA Approvals
